Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Frataxin pseudogene (ENSG00000249418) is a genomic DNA sequence that resembles the functional frataxin (FXN) gene but does not produce a functional protein product. Pseudogenes typically arise by gene duplication or retrotransposition and subsequently accumulate mutations that prevent them from expressing functional proteins. As such, frataxin pseudogene does not have a known biological function, is not implicated in disease, and is not a target for any therapeutic intervention. The functional frataxin gene, by contrast, codes for a mitochondrial protein involved in iron-sulfur cluster assembly and whose deficiency causes Friedreich's ataxia—a neurodegenerative disorder[1][3][2]. However, none of these properties apply to the pseudogene form. Key distinctions: This entry is for a pseudogene, not the protein-coding FXN gene or frataxin protein. If you want information on the functional, disease-relevant protein or drug target, you should query the canonical frataxin (FXN) gene, not a pseudogene locus.
none (not applicable; pseudogenes are not targeted by mechanism-based drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Frataxin pseudogene (none).